3,486 Shares in Axon Enterprise, Inc $AXON Purchased by Elevation Point Wealth Partners LLC

Elevation Point Wealth Partners LLC purchased a new stake in Axon Enterprise, Inc (NASDAQ:AXON) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,486 shares of the biotechnology company’s stock, valued at approximately $1,954,000.

Other hedge funds have also recently bought and sold shares of the company. Creative Financial Designs Inc. ADV purchased a new stake in Axon Enterprise during the 4th quarter worth approximately $28,000. Camelot Portfolios LLC purchased a new position in shares of Axon Enterprise during the 4th quarter valued at approximately $30,000. Keating Financial Advisory Services Inc. purchased a new position in shares of Axon Enterprise during the 2nd quarter valued at approximately $31,000. AlphaCentric Advisors LLC acquired a new stake in shares of Axon Enterprise during the fourth quarter worth approximately $34,000. Finally, Darwin Wealth Management LLC acquired a new stake in shares of Axon Enterprise during the second quarter worth approximately $37,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

AXON has been the topic of several recent analyst reports. Citizens Jmp reaffirmed a “market outperform” rating and issued a $700.00 price target on shares of Axon Enterprise in a report on Thursday, June 25th. The Goldman Sachs Group reissued a “buy” rating and set a $715.00 price objective on shares of Axon Enterprise in a report on Thursday, August 6th. Weiss Ratings reissued a “hold (c-)” rating on shares of Axon Enterprise in a research report on Wednesday, August 5th. Royal Bank Of Canada restated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, July 21st. Finally, UBS Group increased their price target on shares of Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a research report on Thursday, August 6th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average price target of $730.92.

Axon Enterprise Price Performance

AXON stock opened at $627.75 on Monday. The firm has a market cap of $51.00 billion, a price-to-earnings ratio of 260.48, a PEG ratio of 10.19 and a beta of 1.39. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $794.29. The firm has a fifty day moving average price of $543.11 and a two-hundred day moving average price of $476.99. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.80.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The company had revenue of $904.39 million for the quarter, compared to the consensus estimate of $876.42 million. During the same period last year, the firm posted $2.12 EPS. The company’s revenue for the quarter was up 35.3% on a year-over-year basis. Research analysts predict that Axon Enterprise, Inc will post 2.04 EPS for the current year.

Insider Buying and Selling at Axon Enterprise

In other news, President Joshua Isner sold 13,000 shares of the stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $488.45, for a total transaction of $6,349,850.00. Following the sale, the president directly owned 169,125 shares in the company, valued at approximately $82,609,106.25. This represents a 7.14% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CRO Cameron Brooks sold 1,242 shares of the firm’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $500.00, for a total value of $621,000.00. Following the completion of the sale, the executive directly owned 49,710 shares in the company, valued at approximately $24,855,000. This trade represents a 2.44% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 66,989 shares of company stock worth $35,216,932. Corporate insiders own 4.20% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.